Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/01/23 07:01:28 on US and Canada Markets.
Atlantica Reports Second Quarter 20 2 3 Financial Results Revenue for the first half of 2023 reached $554.6 million, a 1.4% increase year-over-year on a comparable basis 1 and a 0.1% decrease year-over-year. Adjusted EBITDA was $403.8 million for the first half...
Same-restaurant sales growth of 7.8% Income from operations margin of 5.3% and Restaurant level operating profit margin of 20.9% Net income of $8.0 million and Adjusted EBITDA of $25.8 million 9 system-wide restaurants opened across 6 states Raising 2023 Adjusted EBITDA gu...
EASTERSEALS DISABILITY ADVOCATES AND ALLIES AUTHOR NEW BIOGRAPHY SERIES FOR CHILDREN HIGHLIGHTING ROLE MODELS AND HISTORICAL FIGURES WITH DISABILITIES PR Newswire CHICAGO , Aug. 1, 2023 /PRNewswire/ -- Easterseals, a leading national nonprofit provider of service...
Vancouver, B.C, Aug. 01, 2023 (GLOBE NEWSWIRE) -- CryptoBlox Technologies Inc. (the “ Company ” or “ CryptoBlox ”) (CSE: BLOX), is pleased to announce the successful acquisition and implementation of a modular data centre (the “ Data Centre ” ...
-- Second quarter 2023 net revenue of $19.2 million from global sales of IMCIVREE ® (setmelanotide) -- -- Strong U.S. commercial progress continues with more than 125 new prescriptions for Bardet-Biedl syndrome (BBS) in 2Q 2023, more than 425 since FDA approval -- ...
R evolution Medicines Expect s to Conduct Late-Stage Development of RAS(ON) I nhibitor Drug C andidate Pipeline Supported by Fortified Balance Sheet Agreement is the Result of a Rigorous Process Conducted by Independe...
Encinitas, California--(Newsfile Corp. - August 1, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has appointed Carmine Stengone as an independent member to the Company's board of directors. Stengone currently serves as the President and CEO of Pipeline Therapeutics, a company developing prec...
– First participant is expected to be dosed in September 2023 with data anticipated in the second half of 2024 – – Cash runway extended through the end of 2025 – BOSTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: T...
- Launched expansion to nearly double hydropower capacity to 350 MW - - Hosting Bitfarms Analyst Day on September 14 th in New York City - This news release constitutes a “designated news release” for purposes of the Company’s prospectus supplement dated...
Financing, available in multiple tranches over the next three years, could extend the Company’s runway into Q4 2024 Transaction will enable Evaxion to advance its next-generation cancer vaccine, EVX-03, towards a Phase 1 clinical trial Copenhagen, DENMARK, Aug. 01, 2023 (GLOBE NE...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
11.5%Change Percent:
111 Inc. Company Name:
YI Stock Symbol:
NASDAQ Market:
ir.111.com.cn Website: